Lawrence G. Hamel
2017
In 2017, Lawrence G. Hamel earned a total compensation of $595.2K as Chief Development Officer at AcelRx Pharmaceuticals, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $90,846 |
|---|---|
| Option Awards | $152,008 |
| Salary | $341,525 |
| Other | $10,800 |
| Total | $595,179 |
Hamel received $341.5K in salary, accounting for 57% of the total pay in 2017.
Hamel also received $90.8K in non-equity incentive plan, $152K in option awards and $10.8K in other compensation.
Rankings
In 2017, Lawrence G. Hamel's compensation ranked 11,232nd out of 14,666 executives tracked by ExecPay. In other words, Hamel earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,232 out of 14,666 | 23rd |
Division Manufacturing | 4,403 out of 5,772 | 24th |
Major group Chemicals And Allied Products | 1,600 out of 2,075 | 23rd |
Industry group Drugs | 1,318 out of 1,731 | 24th |
Industry Pharmaceutical Preparations | 1,032 out of 1,333 | 23rd |
Source: SEC filing on April 23, 2018.
Hamel's colleagues
We found seven more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2017.
2017
Vincent Angotti
AcelRx Pharmaceuticals
Chief Executive Officer
2017
Pamela Palmer
AcelRx Pharmaceuticals
Chief Medical Officer
2017
Howard Rosen
AcelRx Pharmaceuticals
Chief Executive Officer
2017
Raffi Asadorian
AcelRx Pharmaceuticals
Chief Financial Officer
2017
Badri Dasu
AcelRx Pharmaceuticals
Chief Engineering Officer
2017
Timothy Morris
AcelRx Pharmaceuticals
Chief Financial Officer
2017
Jane Wright-Mitchell
AcelRx Pharmaceuticals